ING Groep NV Has $1.90 Million Holdings in DaVita Inc. (NYSE:DVA)

ING Groep NV decreased its stake in shares of DaVita Inc. (NYSE:DVA) by 58.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 11,571 shares of the company’s stock after selling 16,492 shares during the period. ING Groep NV’s holdings in DaVita were worth $1,897,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in DVA. Empowered Funds LLC bought a new position in shares of DaVita in the first quarter valued at approximately $404,000. Sei Investments Co. grew its stake in DaVita by 21.3% in the 1st quarter. Sei Investments Co. now owns 41,952 shares of the company’s stock valued at $5,790,000 after buying an additional 7,371 shares during the last quarter. State Board of Administration of Florida Retirement System raised its holdings in DaVita by 8.3% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 73,574 shares of the company’s stock worth $10,157,000 after acquiring an additional 5,625 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in DaVita by 13.5% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 61,570 shares of the company’s stock worth $8,500,000 after acquiring an additional 7,300 shares during the last quarter. Finally, Banco Santander S.A. acquired a new stake in shares of DaVita in the first quarter valued at about $422,000. 90.12% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. TD Cowen increased their target price on DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research note on Wednesday, July 24th. Truist Financial raised their price objective on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. UBS Group increased their price target on shares of DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Bank of America boosted their price objective on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a report on Wednesday, August 7th. Finally, Barclays upped their price objective on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $161.80.

DaVita Trading Up 3.9 %

Shares of DVA stock opened at $160.33 on Friday. DaVita Inc. has a 52-week low of $92.68 and a 52-week high of $168.50. The stock has a market cap of $13.15 billion, a price-to-earnings ratio of 17.30, a P/E/G ratio of 0.89 and a beta of 0.89. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The firm has a fifty day moving average of $157.78 and a 200-day moving average of $147.56.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.76 by ($0.17). The business had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period last year, the company earned $2.85 EPS. On average, equities research analysts forecast that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Joel Ackerman sold 64,029 shares of DaVita stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the completion of the transaction, the chief financial officer now directly owns 111,481 shares of the company’s stock, valued at $17,286,243.86. This trade represents a 36.48 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Javier Rodriguez sold 50,000 shares of the company’s stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the sale, the chief executive officer now directly owns 837,835 shares in the company, valued at $138,284,666.75. This represents a 5.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 156,086 shares of company stock worth $24,807,161 in the last 90 days. 2.00% of the stock is owned by company insiders.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.